A recent study by Hidese et al. (2020) comparing S100B levels in cerebrospinal fluid of schizophrenic, bipolar disorder, and major depressive disorder patients detected significantly lower S100B concentrations in treated patients in comparison with drug-free patients only with bipolar disorder34. This evidence concerns the gene S100B and major depressive disorder.